Apellis Pharmaceuticals, Inc. (APLS) vs Blueprint Medicines Corporation (BPMC)
Detailed comparison between Apellis Pharmaceuticals, Inc., Blueprint Medicines Corporation.Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)Blueprint Medicines Corporation (BPMC)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
Blueprint Medicines Corporation
BPMC
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | Blueprint Medicines Corporation (BPMC) |
|---|---|---|
| Current Price | $27.54 | $93.30 |
| Change | 0.02 (0.07%) | 1.05 (1.14%) |
| Market Cap | $3.43B | $5.96B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -32.79 | -99.26 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $71.90 | $121.90 |
| 52-Week Low | $24.34 | $80.67 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.03 | $-1.07 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -7.55% | -7.55% | -61.61% | -20.20% | 96.29% | 96.29% |
| BPMC | -18.07% | -18.07% | -1.84% | 57.44% | 394.44% | 394.44% |